Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in DNA gyrase
by Most Patent Filings in the world in 2022

The DNA gyrase top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filings DNA gyrase Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
DNA gyrase, or simply gyrase, is an enzyme within the class of topoisomerase and is a subclass of Type II topoisomerases that reduces topological strain in an ATP dependent manner while double-stranded DNA is being unwound by elongating RNA-polymerase or by helicase in front of the progressing replication fork. The enzyme causes negative supercoiling of the DNA or relaxes positive supercoils. It does so by looping the template so as to form a crossing, then cutting one of the double helices and passing the other through it before releasing the break, changing the linking number by two in each enzymatic step. This process occurs in bacteria, whose single circular DNA is cut by DNA gyrase and the two ends are then twisted around each other to form supercoils. Gyrase is also found in eukaryotic plastids: it has been found in the apicoplast of the malarial parasite Plasmodium falciparum and in chloroplasts of several plants. Bacterial DNA gyrase is the target of many antibiotics, including nalidixic acid, novobiocin, and ciprofloxacin.
#
Company Name
Region
Tech Topics
Total
1
Clinical trial,Cardiovascular agent,Drug,
...[+2]
Patent: 29
2
Germany
Patent: 22
3
Cambridgeshire, United Kingdom
Medicine,Health care,Side effect,
...[+2]
Patent: 18
4
Cambridgeshire, United Kingdom
Patent: 18
5
Patent: 9
6
Patent: 8
7
Switzerland
Medicine,Health care,Drug,
...[+2]
Patent: 7
8
Medicine,Health care,Toxoid,
...[+2]
Patent: 5
9
Haryana, India
Health care,Drug,Active ingredient,
...[+2]
Patent: 5
10
Maharashtra, India
Diabetology,Cephalosporin,Biotechnology,
...[+2]
Patent: 4
Page generation time: Dec 07 2025